Insights and Stories on Bayer

Oct. 22, 2019 at 3:57 pm CDT

Brussels | Reuters — European Union governments on Tuesday widened the EU ban on neonicotinoid pesticides after deciding not to renew their approval for Bayer’s thiacloprid. Farmers will not be allowed to use the neonic insecticide, sold under the brands Calypso and Biscaya, after April 30, 2020, when its current […]

By Reuters

Sep. 11, 2019 at 5:22 am CDT

Winnipeg/Chicago | Reuters — Bunge, one the world’s biggest grain traders, recently disclosed the 1.6 per cent stake it had purchased in the fast-growing fake-meat startup Beyond Meat. The play looked smart after the stock surged more than 250 per cent since the faux burger and sausage maker’s initial public […]

By Rod Nickel, Tom Polansek

Aug. 20, 2019 at 1:33 pm CDT

Reuters — Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit on Tuesday in a cash and stock deal valued at US$7.6 billion (C$10 billion), creating the second largest maker of medicines for livestock and pets and expanding Elanco’s reach online. The deal is the latest in the fast-growing […]

By Ludwig Burger

Aug. 11, 2019 at 12:22 am CDT

New York/Frankfurt | Reuters — Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said, dismissing a report to that effect which drove its shares as much as 11 per cent higher. “Bayer has […]

By jonathan-stempel, Ludwig Burger

Aug. 7, 2019 at 4:35 pm CDT

Reuters — Germany’s Bayer and U.S. drug firm Elanco Animal Health aim to reach an agreement to combine their animal health businesses as soon as next week, Bloomberg reported Wednesday, citing people with knowledge of the matter. Elanco plans to pay for at least a part of the deal with […]

By Reuters